OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 95 filers reported holding OVID THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $84,776 | +10.8% | 22,077 | -5.4% | 0.00% | – |
Q2 2023 | $76,513 | +21.9% | 23,327 | -4.1% | 0.00% | – |
Q1 2023 | $62,766 | +38.7% | 24,328 | 0.0% | 0.00% | – |
Q4 2022 | $45,250 | -20.6% | 24,328 | -22.1% | 0.00% | – |
Q3 2022 | $57,000 | -14.9% | 31,228 | 0.0% | 0.00% | – |
Q2 2022 | $67,000 | -63.4% | 31,228 | -46.5% | 0.00% | -100.0% |
Q1 2022 | $183,000 | -37.3% | 58,365 | -35.8% | 0.00% | 0.0% |
Q4 2021 | $292,000 | -10.4% | 90,852 | -6.3% | 0.00% | 0.0% |
Q3 2021 | $326,000 | -28.7% | 96,998 | -16.9% | 0.00% | -50.0% |
Q2 2021 | $457,000 | -27.3% | 116,760 | -25.4% | 0.00% | 0.0% |
Q1 2021 | $629,000 | +97.8% | 156,482 | +13.7% | 0.00% | +100.0% |
Q4 2020 | $318,000 | -66.4% | 137,660 | -16.4% | 0.00% | -75.0% |
Q3 2020 | $946,000 | +65.4% | 164,736 | +112.4% | 0.00% | +33.3% |
Q2 2020 | $572,000 | +194.8% | 77,556 | +19.3% | 0.00% | +200.0% |
Q1 2020 | $194,000 | -75.4% | 65,000 | -65.8% | 0.00% | -75.0% |
Q4 2019 | $790,000 | – | 190,253 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |